Kendall Capital Management’s Chevron CVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$442K Buy
2,135
+70
+3% +$12.8K 0.09% 166
2025
Q4
$315K Sell
2,065
-37
-2% -$5.63K 0.07% 188
2025
Q3
$326K Sell
2,102
-5
-0.2% -$774 0.07% 191
2025
Q2
$302K Sell
2,107
-11
-0.5% -$1.55K 0.08% 187
2025
Q1
$354K Hold
2,118
0.1% 165
2024
Q4
$307K Buy
2,118
+330
+18% +$50.5K 0.09% 181
2024
Q3
$263K Hold
1,788
0.08% 193
2024
Q2
$280K Hold
1,788
0.09% 182
2024
Q1
$282K Hold
1,788
0.1% 180
2023
Q4
$267K Hold
1,788
0.1% 180
2023
Q3
$301K Sell
1,788
-145
-8% -$23.4K 0.13% 155
2023
Q2
$304K Sell
1,933
-20
-1% -$3.21K 0.13% 158
2023
Q1
$319K Buy
1,953
+11
+0.6% +$1.84K 0.15% 145
2022
Q4
$349K Buy
1,942
+136
+8% +$23.7K 0.18% 136
2022
Q3
$259K Buy
1,806
+87
+5% +$13.3K 0.15% 144
2022
Q2
$249K Hold
1,719
0.14% 150
2022
Q1
$280K Hold
1,719
0.14% 151
2021
Q4
$202K Buy
+1,719
New +$195K 0.1% 161
2021
Q2
Sell
-2,123
Closed -$222K 151
2021
Q1
$222K Buy
+2,123
New +$207K 0.14% 134

Other funds holding CVX

Kendall Capital Management's CVX Position: Q1 2026 in Review

Kendall Capital Management increased its Chevron (CVX) stake by 3.4% in Q1 2026, buying an estimated $12.8K and bringing the position to 2,135 shares worth $442K. The position accounts for 0.09% of the portfolio, ranked #166.

Kendall Capital Management first reported a position in CVX in Q1 2021 and has held it in 19 quarters since. 4,266 funds tracked by Wall St. Rank hold CVX as of Q1 2026.

  • Kendall Capital Management held 2,135 shares of Chevron worth $442K as of Q1 2026.
  • Kendall Capital Management bought 70 Chevron shares in Q1 2026, an estimated $12.8K.
  • Chevron made up 0.09% of Kendall Capital Management's portfolio in Q1 2026, its #166 holding.
  • Kendall Capital Management first reported a position in Chevron in Q1 2021 and has held it in 19 quarters since.
  • 4,266 funds tracked by Wall St. Rank held Chevron as of Q1 2026.

Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.